ProVIDE Studies Post Exit Analysis

NCT07680543 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-09-03

No results posted yet for this study

Summary

A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.

Conditions

  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

DEVICE

ProVee Urethral Expander System

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Sponsors & Collaborators

  • ProVerum Medical

    lead INDUSTRY

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2029-07-31
Completion
2029-07-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07680543 on ClinicalTrials.gov